Non-small cell lung cancer
Conditions
Interventions
Group that received postoperative EGFR-TKIs targeted therapy:None
Group that did not receive postoperative EGFR-TKIs targeted therapy:None
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Pathologically confirmed non-small cell lung cancer; (2) The age at diagnosis of non-small cell lung cancer was greater than or equal to 18 years old; (3) According to the Ninth Edition TNM staging of lung cancer (AJCC 9th Edition), the postoperative pathological diagnosis was stage IA non-small cell lung cancer; (4) Treatment group: patients continued to receive postoperative EGFR TKIs targeted therapy for more than 12 months; (5) Observation group: patients did not receive EGFR TKIs targeted therapy from the operation date to the last follow-up
Exclusion criteria
Exclusion criteria: (1) Incomplete baseline or prognostic information; (2) Incomplete important clinical data information; (3) No more than 3 months from receiving surgery to the occurrence of the endpoint event; (4) Other malignant tumors were combined at the time of diagnosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival period; | — |
Countries
China
Contacts
Public ContactJian Zhou
West China Hospital of Sichuan University
Outcome results
None listed